Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

h-index111
i10-index484
Publications1,980
Citations59,037

Grants

40 total · 9 active

NIH #5K12CA088084-24

Paul Calabresi Clinical Oncology Award

Active
Amount
$805K
Period
2000-09-13 → 2027-06-30
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5K12CA088084-23

Paul Calabresi Clinical Oncology Award

Active
Amount
$570K
Period
2000-09-13 → 2027-06-30
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5K12CA088084-22

Paul Calabresi Clinical Oncology Award

Active
Amount
$663K
Period
2000-09-13 → 2027-06-30
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

40 total · 9 active

NIH #5K12CA088084-24

Paul Calabresi Clinical Oncology Award

Active
Amount
$805K
Period
2000-09-13 → 2027-06-30
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5K12CA088084-23

Paul Calabresi Clinical Oncology Award

Active
Amount
$570K
Period
2000-09-13 → 2027-06-30
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5K12CA088084-22

Paul Calabresi Clinical Oncology Award

Active
Amount
$663K
Period
2000-09-13 → 2027-06-30
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #2K12CA088084-21

Paul Calabresi Clinical Oncology Award

Active
Amount
$692K
Period
2000-09-13 → 2027-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA262805-05

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$712K
Period
2022-04-01 → 2027-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5R01CA262805-04

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$712K
Period
2022-04-01 → 2027-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5R01CA262805-03

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$676K
Period
2022-04-01 → 2027-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5R01CA262805-02

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$698K
Period
2022-04-01 → 2027-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #1R01CA262805-01A1

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$729K
Period
2022-04-01 → 2027-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5P30CA016672-49

07 Gastrointestinal Cancers

Amount
$25K
Period
1996-08-28 → 2026-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #4P30CA016672-48

07 Gastrointestinal Cancers

Amount
$23K
Period
1996-08-28 → 2026-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5UH3CA207101-05

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$150K
Period
2018-09-21 → 2025-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5U24CA220325-05

MDACC-PREDICT

Amount
$658K
Period
2020-09-01 → 2025-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-05

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

Amount
$2.2M
Period
2019-08-20 → 2025-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5UH3CA207101-04

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$341K
Period
2018-09-21 → 2024-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #4UH3CA207101-03

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$297K
Period
2018-09-21 → 2024-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P30CA016672-47

07 Gastrointestinal Cancers

Amount
$19K
Period
1996-08-28 → 2024-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA218230-05

Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies

Amount
$651K
Period
2018-07-01 → 2024-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P30CA016672-46

07 Gastrointestinal Cancers

Amount
$19K
Period
1996-08-28 → 2024-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P30CA016672-45

07 Gastrointestinal Cancers

Amount
$19K
Period
1996-08-28 → 2024-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-04

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

Amount
$2.2M
Period
2019-08-20 → 2024-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-03

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

Amount
$2.0M
Period
2019-08-20 → 2024-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-02

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

Amount
$2.3M
Period
2019-08-20 → 2024-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5U24CA220325-04

MDACC-PREDICT

Amount
$670K
Period
2020-09-01 → 2023-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #7U24CA220325-03

MDACC-PREDICT

Amount
$670K
Period
2020-09-01 → 2023-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #3U54CA224065-04S2

Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer

Amount
$97K
Period
2017-09-30 → 2023-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA218230-04

Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies

Amount
$664K
Period
2018-07-01 → 2023-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5U54CA224065-04

Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer

Amount
$218K
Period
2017-09-30 → 2023-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA218230-03

Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies

Amount
$664K
Period
2018-07-01 → 2023-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA218230-02

Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies

Amount
$644K
Period
2018-07-01 → 2023-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #3U54CA224065-03S1

Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer

Amount
$120K
Period
2017-09-30 → 2022-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5U54CA224065-03

Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer

Amount
$223K
Period
2017-09-30 → 2022-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA184843-05

Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition

Amount
$613K
Period
2015-02-13 → 2021-01-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5UH2CA207101-02

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$164K
Period
2018-09-21 → 2020-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1UH2CA207101-01A1

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$214K
Period
2018-09-21 → 2020-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA187238-05

Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer

Amount
$332K
Period
2014-08-04 → 2020-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P30CA016672-44

07 Gastrointestinal Cancers

Amount
$19K
Period
— → —
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1P50CA221707-01A1

Administrative Core

Amount
$274K
Period
— → —
PIs
1
Est. capacity / PI
~4 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #3P30CA016672-43S1

07 Gastrointestinal Cancers

Amount
$5K
Period
— → —
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #2P30CA016672-43

07 Gastrointestinal Cancers

Amount
$19K
Period
— → —
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 335
Open author page on OpenAlex →